eHealth Held a Successful Investor & Analyst Day Event in New York City
The company provided 3-year financial targets
The presentation slides and webcast replay are available on eHealth's Investor Relations site.
"Thursday's Investor & Analyst Day marks an important milestone in eHealth's transformational journey," said eHealth CEO
During his presentation,
- Enrollment growth in direct-to-consumer products, including Medicare Advantage and Individual & Family Plans, is outpacing growth in group products, driven by the increased consumerism of health care and favorable demographic trends.
- Insurance carriers rely on a diversified distribution model to deliver on their enrollment and acquisition cost targets. Tele/e-broker enrollment contributions to annual enrollment have grown significantly in recent years.
- eHealth offers carriers reliable, high-quality volume. eHealth appeals to segments of the population that are more tech-savvy and favor a comparison shopping model over direct enrollment through a single carrier. We believe carriers value partnerships with brokers like eHealth that provide access to otherwise hard to reach customer audiences and that can collaborate with carriers on post-enrollment member engagement.
- eHealth offers consumers true omni-channel, carrier-agnostic comparison shopping. We see eHealth's technology-driven choice model as a significant competitive differentiator and the company's transformation plan is designed to further enhance its value proposition.
- The company believes that industry inflection will favor brokers like eHealth with a strong financial profile and a focus on profitability. With 25 years of leadership in the market and a strong new executive leadership team, we believe that eHealth is well positioned for sustainable profitable growth.
At the Investor & Analyst Day event, eHealth provided intermediate financial targets through 2025 including:
- Revenue growth of 8% to 10% annually in 2024 and 2025
- Adjusted EBITDA margin of 8% to 10% by 2025
- Achieving break-even cash flow from operations for the trailing twelve-month period ending
March 2024 - Achieving positive cash flow from operations for the trailing twelve-month period ending
March 2025
Additional detailed presentations were made during eHealth's Investor & Analyst Day event by
For a full recording of eHealth's Investor & Analyst Day webcast visit ir.ehealthinsurance.com.
About eHealth
For over 25 years,
Forward-Looking Statements
This press release includes forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally relate to future events or our future financial or operating performance. Forward-looking statements in this press release include, but are not limited to, the following: the impact of our transformation plan; our expectations regarding our business, including our market opportunity, competitive advantage, strategy, investments and long-term vision; our expectations and predictions for our industry; our relationships with carriers; our projection for operating cash flow; and our financial targets, including those for revenue growth, adjusted EBITDA margin and operating cash flow.
Our expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. These risks include those set forth in our filings with the
Non-GAAP Information
Adjusted EBITDA margin is a non-GAAP financial measure. However, the range of adjusted EBITDA margin included in this press release is a target for 2025 based on eHealth's operating model, not forward-looking guidance. A reconciliation to the most directly comparable GAAP financial measure is unavailable without unreasonable effort. Adjusted EBITDA margin is calculated by dividing adjusted EBITDA by revenue. Adjusted EBITDA is calculated by excluding the paid-in-kind dividends for preferred stock and change in preferred stock redemption value, income tax expense (benefit), depreciation and amortization, stock-based compensation expense, impairment, restructuring and other charges, other income (expense), net, and other non-recurring charges from GAAP net income (loss) attributable to common stockholders. Other non-recurring charges to GAAP net income (loss) attributable to common stockholders may include transaction expenses in connection with capital raising transactions (whether debt, equity or equity-linked) and acquisitions, whether or not consummated, purchase price adjustments and the cumulative effect of a change in accounting principles.
Investor Relations Contact:
Senior Vice President, Investor Relations & Strategy
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/ehealth-held-a-successful-investor--analyst-day-event-in-new-york-city-301830453.html
SOURCE
Certain Radnor Re Entities Announce Results of Tender Offers for Certain Outstanding Series 2019-1 and 2020-1 Mortgage Insurance-Linked Notes
Travelers Data Shows Collisions, Weather Among Most Common Boating Claims
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News